ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA.
Department of Pathology, Clarient Pathology Services, Aliso Viejo, CA, USA.
Mod Pathol. 2017 Sep;30(9):1234-1240. doi: 10.1038/modpathol.2017.50. Epub 2017 Jul 28.
Juvenile xanthogranuloma is a rare histiocytic proliferation primarily affecting infants and young children, characterized by aberrant infiltration of histiocyte-derived cells in the skin, soft tissues and more rarely, visceral organs. Juvenile xanthogranuloma is generally considered to be a benign disorder; most lesions are solitary cutaneous nodules that resolve spontaneously without treatment. However, cases with extracutaneous involvement, multiple lesions, and/or systemic disease often require aggressive therapy. Though molecular studies have provided evidence of clonality in juvenile xanthogranuloma, in support of a neoplastic process, little is known about the genetic profile of juvenile xanthogranuloma. We used molecular inversion probe array technology to evaluate the genomic characteristics (copy number alterations or copy neutral-loss of heterozygosity) of 21 archived cases of juvenile xanthogranuloma (19 solitary, 1 diffuse cutaneous, 1 systemic). Four cases (19%) showed acquired, clonal alterations. Two lesions from a case of diffuse cutaneous juvenile xanthogranuloma showed distinct profiles: JXG-1a contained trisomy 5 and 17 and JXG-1b contained loss of heterozygosity in 5q. The systemic juvenile xanthogranuloma (JXG-2) showed multiple genomic alterations. Only two of 19 solitary juvenile xanthogranulomas showed abnormal genomic profiles: JXG-3 showed gains on 1q and 11q and JXG-4 showed a 7.2 Mb loss in 3p. No recurrent abnormalities were observed among these cases. The presence of non-recurrent copy number alterations in a subset of samples implies that copy number changes are unlikely driving pathogenesis in juvenile xanthogranuloma, but may be acquired during disease progression. The presence of genomic abnormalities in more advanced cases (ie, systemic and diffuse cutaneous juvenile xanthogranuloma) supports this notion, particularly as the advanced cases of juvenile xanthogranuloma presented more genomic complexity.
幼年黄色肉芽肿是一种罕见的组织细胞增生症,主要影响婴儿和幼儿,其特征是组织细胞来源的细胞异常浸润皮肤、软组织,更罕见地浸润内脏器官。幼年黄色肉芽肿一般被认为是一种良性疾病;大多数病变为单发的皮肤结节,不经治疗可自发消退。然而,有皮肤外累及、多发病变和/或全身疾病的病例常需要积极治疗。虽然分子研究为幼年黄色肉芽肿存在克隆性提供了证据,支持肿瘤性过程,但对幼年黄色肉芽肿的遗传特征知之甚少。我们使用分子反转探针阵列技术评估了 21 例存档的幼年黄色肉芽肿病例(19 例单发、1 例播散性皮肤、1 例系统性)的基因组特征(拷贝数改变或非整倍体性杂合性缺失)。4 例(19%)表现出获得性、克隆性改变。1 例播散性幼年黄色肉芽肿的 2 个病变显示出不同的特征:JXG-1a 包含 5 号和 17 号三体,JXG-1b 包含 5q 杂合性缺失。系统性幼年黄色肉芽肿(JXG-2)显示出多种基因组改变。19 例单发幼年黄色肉芽肿中只有 2 例显示异常的基因组特征:JXG-3 显示 1q 和 11q 的增益,JXG-4 显示 3p 上 7.2Mb 的缺失。这些病例中未观察到重复异常。在亚组样本中存在非重复的拷贝数改变表明,拷贝数改变不太可能是幼年黄色肉芽肿发病机制的驱动因素,而是可能在疾病进展过程中获得的。在更晚期的病例(即系统性和播散性幼年黄色肉芽肿)中存在基因组异常支持了这一观点,特别是在更晚期的幼年黄色肉芽肿病例中表现出了更多的基因组复杂性。